342 related articles for article (PubMed ID: 29467215)
1. Identification of Intestinal UDP-Glucuronosyltransferase Inhibitors in Green Tea (
Tian DD; Kellogg JJ; Okut N; Oberlies NH; Cech NB; Shen DD; McCune JS; Paine MF
Drug Metab Dispos; 2018 May; 46(5):552-560. PubMed ID: 29467215
[TBL] [Abstract][Full Text] [Related]
2. Co-consuming green tea with raloxifene decreases raloxifene systemic exposure in healthy adult participants.
Clarke JD; Judson SM; Tian DD; Kirby TO; Tanna RS; Matula-Péntek A; Horváth M; Layton ME; White JR; Cech NB; Thummel KE; McCune JS; Shen DD; Paine MF
Clin Transl Sci; 2023 Oct; 16(10):1779-1790. PubMed ID: 37639334
[TBL] [Abstract][Full Text] [Related]
3. Identification of diet-derived constituents as potent inhibitors of intestinal glucuronidation.
Gufford BT; Chen G; Lazarus P; Graf TN; Oberlies NH; Paine MF
Drug Metab Dispos; 2014 Oct; 42(10):1675-83. PubMed ID: 25008344
[TBL] [Abstract][Full Text] [Related]
4. Targeted screen for human UDP-glucuronosyltransferases inhibitors and the evaluation of potential drug-drug interactions with zafirlukast.
Oda S; Fujiwara R; Kutsuno Y; Fukami T; Itoh T; Yokoi T; Nakajima M
Drug Metab Dispos; 2015 Jun; 43(6):812-8. PubMed ID: 25834030
[TBL] [Abstract][Full Text] [Related]
5. An Appraisal of Drug-Drug Interactions with Green Tea (Camellia sinensis).
Albassam AA; Markowitz JS
Planta Med; 2017 Apr; 83(6):496-508. PubMed ID: 28118673
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of in vitro inhibitors against UDP-glucuronosyltransferase 1A1 in uva-ursi extracts and evaluation of in vivo uva-ursi-drug interactions.
Park JB; Kim D; Min JS; Jeong S; Cho DY; Zheng YF; Yoon KD; Bae SK
Food Chem Toxicol; 2018 Oct; 120():651-661. PubMed ID: 30075316
[TBL] [Abstract][Full Text] [Related]
7. Effects of green tea extract and (-)-epigallocatechin-3-gallate on pharmacokinetics of nadolol in rats.
Misaka S; Miyazaki N; Fukushima T; Yamada S; Kimura J
Phytomedicine; 2013 Nov; 20(14):1247-50. PubMed ID: 23920278
[TBL] [Abstract][Full Text] [Related]
8. Dietary green and white teas suppress UDP-glucuronosyltransferase UGT2B17 mediated testosterone glucuronidation.
Jenkinson C; Petroczi A; Barker J; Naughton DP
Steroids; 2012 May; 77(6):691-5. PubMed ID: 22429924
[TBL] [Abstract][Full Text] [Related]
9. Anti-atherogenic role of green tea (Camellia sinensis) in South Indian smokers.
Kanu VR; Pulakuntla S; Kuruvalli G; Aramgam SL; Marthadu SB; Pannuru P; Hebbani AV; Desai PPD; Badri KR; Vaddi DR
J Ethnopharmacol; 2024 Oct; 332():118298. PubMed ID: 38714238
[TBL] [Abstract][Full Text] [Related]
10. Impact of Bioconversion of Gallated Catechins and Flavonol Glycosides on Bioaccessibility and Intestinal Cellular Uptake of Catechins.
Choi EH; Rha CS; Balusamy SR; Kim DO; Shim SM
J Agric Food Chem; 2019 Feb; 67(8):2331-2339. PubMed ID: 30767525
[TBL] [Abstract][Full Text] [Related]
11. Green Tea Catechins Decrease Solubility of Raloxifene In Vitro and Its Systemic Exposure in Mice.
Oyanna VO; Bechtold BJ; Lynch KD; Ridge Call M; Graf TN; Oberlies NH; Clarke JD
Pharm Res; 2024 Mar; 41(3):557-566. PubMed ID: 38302834
[TBL] [Abstract][Full Text] [Related]
12. Green tea extract-patents and diversity of uses.
Saito ST; Gosmann G; Pungartnik C; Brendel M
Recent Pat Food Nutr Agric; 2009 Nov; 1(3):203-15. PubMed ID: 20653541
[TBL] [Abstract][Full Text] [Related]
13. White and green teas (Camellia sinensis var. sinensis): variation in phenolic, methylxanthine, and antioxidant profiles.
Unachukwu UJ; Ahmed S; Kavalier A; Lyles JT; Kennelly EJ
J Food Sci; 2010 Aug; 75(6):C541-8. PubMed ID: 20722909
[TBL] [Abstract][Full Text] [Related]
14. Glucuronidation of mono(2-ethylhexyl) phthalate in humans: roles of hepatic and intestinal UDP-glucuronosyltransferases.
Hanioka N; Kinashi Y; Tanaka-Kagawa T; Isobe T; Jinno H
Arch Toxicol; 2017 Feb; 91(2):689-698. PubMed ID: 27071666
[TBL] [Abstract][Full Text] [Related]
15. Tea enhances insulin activity.
Anderson RA; Polansky MM
J Agric Food Chem; 2002 Nov; 50(24):7182-6. PubMed ID: 12428980
[TBL] [Abstract][Full Text] [Related]
16. Novel inhibitors of fatty-acid synthase from green tea (Camellia sinensis Xihu Longjing) with high activity and a new reacting site.
Zhang R; Xiao W; Wang X; Wu X; Tian W
Biotechnol Appl Biochem; 2006 Jan; 43(Pt 1):1-7. PubMed ID: 15943584
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of acetylcholinesterase by green and white tea and their simulated intestinal metabolites.
Okello EJ; Leylabi R; McDougall GJ
Food Funct; 2012 Jun; 3(6):651-61. PubMed ID: 22418730
[TBL] [Abstract][Full Text] [Related]
18. Quantification of ascorbyl adducts of epigallocatechin gallate and gallocatechin gallate in bottled tea beverages.
Hung WL; Wang S; Sang S; Wan X; Wang Y; Ho CT
Food Chem; 2018 Sep; 261():246-252. PubMed ID: 29739590
[TBL] [Abstract][Full Text] [Related]
19. Safety assessment of green tea based beverages and dried green tea extracts as nutritional supplements.
Dekant W; Fujii K; Shibata E; Morita O; Shimotoyodome A
Toxicol Lett; 2017 Aug; 277():104-108. PubMed ID: 28655517
[TBL] [Abstract][Full Text] [Related]
20. In vitro human skin permeation and cutaneous metabolism of catechins from green tea extract and green tea extract-loaded chitosan microparticles.
Wisuitiprot W; Somsiri A; Ingkaninan K; Waranuch N
Int J Cosmet Sci; 2011 Dec; 33(6):572-9. PubMed ID: 21790662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
